Search Results - andreas+tue+ingemann+jensen

1 Results Sort By:
Method for improving delivery of immunotherapeutic agents to the CNS
­Background Up to 1 billion people, suffer from neurological disorders, from Alzheimer (AD) and Parkinson disease, strokes, multiple sclerosis and epilepsy to migraine, brain injuries and neuroinfections. Most therapies fail mainly due to the poor penetration of the blood-brain barrier (BBB). Therefore, improving the delivery of drugs to the CNS...
Published: 11/21/2022   |   Inventor(s): Maiken Nedergaard, Benjamin Plog, Humberto Mestre, Tuomas Olavi Lilius, Andreas Tue Ingemann Jensen, Steven Goldman
Category(s): Therapeutic